SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

UBS Cuts Integra LifeSciences Price Target to $14 From $19

UBS maintained its Neutral rating on Integra LifeSciences.

IART

Related stories